Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00468728
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2007-05-01
Brief Title:
PAR-101OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea CDAD
Sponsor:
Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Optimer Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA